HSCT

Source: Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Late Effects of the Digestive System / Hepatobiliary / Treatment-related risk factors for hepatobiliary late effects

Chronic liver dysfunction in patients after HSCT is multifactorial in etiology with the most common etiologies including iron overload, chronic GVHD, and viral hepatitis.[72]

Source links and citations

Patients with chronic GVHD of the GI tract who exhibit an elevated bilirubin have a worse prognosis and quality of life.[73]

Source links and citations

While chronic liver dysfunction may be seen in more than one-half of long-term HSCT survivors, and the course of the disease appears to be indolent, continued follow-up is needed to establish its long-term impact on survivor health.[74]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice